AULTMAN ORRVILLE HOSPITAL — History
CCN 361323 | 3-year financial timeline | COVID resilience: 76/100
🛡️ Public data only — no PHI permitted on this instance.
$58M
Latest Revenue (FY2022)
+19.6%
Revenue CAGR (3yr)
3.3%
Financial Timeline
| Metric | FY2020 | FY2021 | FY2022 | YoY (Latest) | CAGR |
|---|---|---|---|---|---|
| Net Patient Revenue | $41M | $57M | $58M | +2.4% | +19.6% |
| Operating Expenses | $42M | $50M | $56M | +12.8% | +16.1% |
| Operating Margin | -2.7% | 12.2% | 3.3% | -73.0% | +0.0% |
| Net Income | $-1M | $7M | $2M | -72.3% | +0.0% |
| Licensed Beds | 25 | 25 | 25 | +0.0% | +0.0% |
| Total Patient Days | 3,125 | 3,550 | 3,409 | -4.0% | +4.4% |
| Medicare Day % | 13% | 13% | 15% | +14.7% | +7.2% |
| Medicaid Day % | 1% | 1% | 2% | +73.6% | +67.0% |
COVID Impact & Recovery
Resilience Score: 76/100 — Resilient — strong COVID recovery
Revenue recovery from FY2020 to FY2022: +43.1% ($41M → $58M)
FY2020 captured the initial COVID shock. Strong recovery indicates operational resilience and payer diversification.
Trend Summary
Revenue▲ Growing
Operating Margin▲ Growing
Beds▶ Stable
Medicare Mix▼ Declining
vs State Average ()
Revenue Growth
+19.6%
This Hospital
+7.6%
State Avg
Latest Margin
3.3%
This Hospital
-4.6%
State Avg
Projections (FY2023-2025)
Extrapolated from 3-year trend using linear projection. Does not account for regulatory or market changes.
| Year | Revenue (proj) | Margin (proj) |
|---|---|---|
| FY2023 (proj) | $67M | 6.3% |
| FY2024 (proj) | $76M | 9.3% |
| FY2025 (proj) | $84M | 12.3% |